European Innovation Council

Sparrow Quantum specializes in developing deterministic single-photon sources for advancing light-matter interfaces in quantum technologies. With a focus on high efficiency, purity, indistinguishability, and outcoupling, the company's technology is based on over two decades of research at the Niels Bohr Institute.

AlzeCure Pharma is a Swedish pharmaceutical company dedicated to developing drug therapies targeting diseases affecting the central nervous system. Its primary focus lies in Alzheimer's disease, with five drug candidates at various stages of development.

Elicera Therapeutics is a clinical-stage immuno-oncology company based in Sweden that focuses on developing innovative cell and gene therapies to treat cancer. The company’s portfolio includes four drug candidates: two oncolytic virus therapies, ELC-100 and ELC-201, and two CAR T-cell treatments, ELC-301 and ELC-401. Additionally, Elicera has developed a universal CAR T-cell technology platform named iTANK (ELC-001), designed to enhance the efficacy of CAR T-cell therapies by enabling a multi-targeted approach against solid tumors. With its commitment to advancing immune-based cancer treatments, Elicera Therapeutics aims to improve outcomes for patients facing various forms of cancer.

Basemark specializes in developing augmented reality software for enhanced driver awareness and safety. It offers tools to avoid occlusion, prevent motion sickness, and support multiple in-vehicle displays, enabling automotive manufacturers to create practical AR applications.

Heart Aerospace AB, established in 2018 with headquarters in Gothenburg, Sweden, and operations in Palo Alto, California, specializes in developing electric regional airliners certified for passenger flight. The company's mission is to facilitate swift, affordable, and sustainable travel for regional journeys worldwide. Their flagship aircraft, the ES-19, is a nineteen-passenger electric airliner designed with an operating range of 400 km, aiming to reduce fuel and maintenance costs compared to traditional aircraft while emitting zero operational emissions. Heart Aerospace targets commercial operation certification for the ES-19 by 2026.

ResoTher Pharma is a privately held biotechnology company based in Copenhagen, Denmark. The company specializes in developing peptide-based drugs derived from Annexin A1, an endogenous immunomodulator. These drugs are designed as resolution therapies for diseases where neutrophil-driven inflammation is a key pathological factor. ResoTher Pharma's primary focus is on addressing cardiovascular and inflammatory disorders that have significant unmet medical needs. Their patented peptide drugs target a G-protein coupled receptor expressed on leukocytes, aiming to mimic the body's natural response to resolving inflammation and promoting tissue repair.

Handiscover Sweden AB is an online booking platform specializing in accommodations for individuals with physical disabilities. Founded in 2014 by Sebastien Archambeaud in response to personal experiences as a parent of a child with a muscle disease, the company is headquartered in Malmö, Sweden. Handiscover features a distinctive classification system that allows users to select accommodations based on varying levels of mobility and physical needs. This community-based platform not only enables individuals with disabilities to find suitable vacation rentals but also assists companies and municipalities in gathering and presenting essential accessibility data. By focusing on the unique requirements of its users, Handiscover aims to enhance the travel experience for people with disabilities, making it easier for them to discover and book accessible holiday accommodations.

Neuro Event Labs Oy, established in 2015 and headquartered in Tampere, Finland, specializes in developing artificial intelligence-based software for epilepsy patient monitoring. Their primary product collects accurate seizure data from patients at home and in hospitals, which is then analyzed and relayed to physicians for informed treatment decisions. This solution was developed in close collaboration with leading Finnish hospitals.

Sparrow Quantum specializes in developing deterministic single-photon sources for advancing light-matter interfaces in quantum technologies. With a focus on high efficiency, purity, indistinguishability, and outcoupling, the company's technology is based on over two decades of research at the Niels Bohr Institute.

Samplix is a biotechnology company based in Herlev, Denmark, that specializes in advanced sample preparation for single DNA and RNA molecules. The company has developed the proprietary Xdrop™ technology, which utilizes a unique "water-oil-water" droplet formation to create millions of reaction chambers for handling individual DNA molecules. This innovative technology allows for targeted enrichment of large DNA fragments, addressing the limitations of existing multi-molecule preparation methods. By enabling precise and sensitive sample preparation, Samplix empowers researchers to conduct more informed studies, facilitating the sequencing of genetic regions critical for understanding virus integration and minimizing unintended CRISPR edits. The Xdrop™ system includes both the instrumentation and consumables needed for effective single-molecule analysis, thereby enhancing the ease of use and efficiency in molecular research.

Samplix is a biotechnology company based in Herlev, Denmark, that specializes in advanced sample preparation for single DNA and RNA molecules. The company has developed the proprietary Xdrop™ technology, which utilizes a unique "water-oil-water" droplet formation to create millions of reaction chambers for handling individual DNA molecules. This innovative technology allows for targeted enrichment of large DNA fragments, addressing the limitations of existing multi-molecule preparation methods. By enabling precise and sensitive sample preparation, Samplix empowers researchers to conduct more informed studies, facilitating the sequencing of genetic regions critical for understanding virus integration and minimizing unintended CRISPR edits. The Xdrop™ system includes both the instrumentation and consumables needed for effective single-molecule analysis, thereby enhancing the ease of use and efficiency in molecular research.

Valo Therapeutics is an immunotherapy company focused on developing antigen-coated oncolytic viruses as therapeutic vaccines for cancer treatment. Founded in 2016 and based in Oxford, United Kingdom, with an additional office in Helsinki, Finland, the company utilizes its innovative Valo Tx platform, which includes PeptiCRAd, an engineered human oncolytic adenovirus. This platform is designed to induce systemic anti-tumor T cell responses by transforming oncolytic adenoviruses into targeted, tissue-specific cancer vaccines without requiring the production of multiple genetically modified viruses. Valo Therapeutics is also advancing other neoantigen strategies, including PeptiENV, in collaboration with Professor Vincenzo Cerullo from the University of Helsinki, to enhance therapeutic responses against various cancer types.

TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, specializing in the development of genetically modified oncolytic viruses to enhance T-cell therapies for cancer treatment. Established in 2013, the company focuses on utilizing its patented technology to improve tumor-infiltrating lymphocyte (TIL) and chimeric antigen receptor (CAR-T) therapies, as well as checkpoint inhibiting antibody treatments. TILT Biotherapeutics is advancing products such as TILT-123, TILT-234, and TILT-321, which aim to modify the tumor microenvironment and boost immune responses against cancer. The company's innovative approach holds promise for achieving effective results in treating solid tumors, paralleling the successes seen in hematological tumors.

TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, specializing in the development of genetically modified oncolytic viruses to enhance T-cell therapies for cancer treatment. Established in 2013, the company focuses on utilizing its patented technology to improve tumor-infiltrating lymphocyte (TIL) and chimeric antigen receptor (CAR-T) therapies, as well as checkpoint inhibiting antibody treatments. TILT Biotherapeutics is advancing products such as TILT-123, TILT-234, and TILT-321, which aim to modify the tumor microenvironment and boost immune responses against cancer. The company's innovative approach holds promise for achieving effective results in treating solid tumors, paralleling the successes seen in hematological tumors.

Modvion AB is a Swedish company founded in 2015 and based in Gothenburg, specializing in the design and development of modular wind power towers constructed from renewable composite materials. The company focuses on simplifying construction logistics and improving cost efficiency in the wind energy sector through its patented modular technology. This innovative approach enables the production of wind towers exceeding 120 meters in height while significantly reducing transportation costs, installation complexity, and the reliance on traditional steel structures. By leveraging engineered wood products, Modvion aims to enhance the economic viability of wind power projects, ultimately contributing to increased electricity production and more sustainable energy solutions.

Founded in 2022, Kvantify is headquartered in Copenhagen, Denmark. It specializes in quantum computing management software, offering solutions to address computational challenges across various industries such as life sciences, financial services, and logistics.

N2 Applied is a Norwegian technology company focused on enabling farmers to produce their own sustainable fertilizer through an innovative process that utilizes slurry, air, and electricity. The company is in the pre-commercial phase and has developed a technology that allows for the local production of nitrogen-rich fertilizer from liquid organic substrates, such as livestock manure. By integrating nitrogen from the atmosphere into these substrates, N2 Applied's solution not only enhances the nitrogen content but also mitigates ammonia loss and reduces greenhouse gas emissions. The company operates its head office in Oslo/Asker and maintains a test center in Svene, with additional branches in Wageningen and York. N2 Applied's scalable process aims to eliminate the lengthy and costly supply chains associated with traditional fertilizer production, facilitating a more circular farming system. This approach not only provides farmers with cost-effective and environmentally friendly fertilizer but also contributes to on-farm reductions in methane and ammonia emissions.

Ekkono Solutions AB develops machine learning for the Internet of Things. It provides an embedded analytics engine that runs on connected devices, handling the full workflow from data input and model training to model deployment, retraining and data output. The company serves IoT applications across industries such as energy, telecom, automotive, agriculture, healthcare and housing automation, as well as consumer IoT products including home security gateways, e-bikes and lawnmower robots. Based in Tvååker, Sweden, Ekkono emphasizes edge processing to learn the normal state of each device, enabling anomaly detection, impact analysis, and proactive planning. By processing data locally, it reduces network load and sends only relevant information to the cloud for further analysis, supporting real-time decisions and end-to-end data management.

Ekkono Solutions AB develops machine learning for the Internet of Things. It provides an embedded analytics engine that runs on connected devices, handling the full workflow from data input and model training to model deployment, retraining and data output. The company serves IoT applications across industries such as energy, telecom, automotive, agriculture, healthcare and housing automation, as well as consumer IoT products including home security gateways, e-bikes and lawnmower robots. Based in Tvååker, Sweden, Ekkono emphasizes edge processing to learn the normal state of each device, enabling anomaly detection, impact analysis, and proactive planning. By processing data locally, it reduces network load and sends only relevant information to the cloud for further analysis, supporting real-time decisions and end-to-end data management.

AcouSort develops and sells laboratory equipment and integrated solutions using ultrasound to separate, wash, and enrich cells, exosomes, and other biological particles for research and diagnostics.

Reliefed Technologies AB, based in Varberg, Sweden, specializes in producing 3D printing components for various manufacturing sectors, including transportation, building materials, consumer products, and energy applications. The company has developed a globally patented 3D-production method called z.trusion®, which allows for the integration of 3D mass production into existing 2D production lines. This innovative technology significantly reduces energy consumption and costs, particularly in the new energy sector, where it can achieve up to 97% less energy usage and ten times higher production speeds. Reliefed Technologies focuses on advanced applications such as bipolar flow plates for fuel cells and electrolyzers, electrodes for lithium-ion batteries, and other energy-efficient solutions. The company is actively involved in industrialization projects with major multinational OEMs and Tier 1 suppliers, holding 44 patents across multiple countries. Through its technology, Reliefed aims to improve product performance and facilitate recycling, while also contributing to substantial savings in material and production costs.

Oivi is a Norwegian company founded in 2017 and based in Oslo, specializing in the development of an affordable AI-driven camera and platform for the identification of diabetic eye diseases. The company focuses on facilitating retinal screening in primary care settings, thereby promoting awareness and proactive management of diabetic eye health. Oivi's innovative platform employs automated image capture and diagnostic capabilities to monitor eye diseases effectively through teleconsultation. With a multifaceted team possessing extensive expertise in camera and software development, Oivi aims to empower patients to prevent permanent vision loss associated with diabetes.

Quanturi Oy is a Finnish company founded in 2016, headquartered in Espoo, with additional locations across Europe, including France, Great Britain, the Netherlands, Switzerland, Italy, and Belgium. The company specializes in developing and providing continuous monitoring solutions for fermentable products, focusing on sectors such as agriculture, forestry, and waste management. Its product offerings include wireless monitoring systems for compost temperature, grain management, and hay, as well as temperature monitoring systems applicable to various other industries. Quanturi Oy also engages in online sales of its innovative solutions, emphasizing the analysis of data associated with its connected objects.

Abzu is a company that develops a scientific artificial intelligence platform aimed at accelerating drug discovery and bringing pharmaceuticals to market more efficiently. Founded in January 2018, with offices in Copenhagen, Denmark, and Barcelona, Spain, Abzu challenges traditional, opaque AI methods by utilizing its pioneering technology, the QLattice. This platform provides transparent and explainable models that enable data scientists to approach their work with a scientific mindset. By unlocking new disease mechanisms, discovering novel biomarkers, and designing improved drugs, Abzu empowers pharmaceutical and biotech companies to validate multiple targets simultaneously, thereby enhancing their research capabilities and reducing development costs.

Quanturi Oy is a Finnish company founded in 2016, headquartered in Espoo, with additional locations across Europe, including France, Great Britain, the Netherlands, Switzerland, Italy, and Belgium. The company specializes in developing and providing continuous monitoring solutions for fermentable products, focusing on sectors such as agriculture, forestry, and waste management. Its product offerings include wireless monitoring systems for compost temperature, grain management, and hay, as well as temperature monitoring systems applicable to various other industries. Quanturi Oy also engages in online sales of its innovative solutions, emphasizing the analysis of data associated with its connected objects.

Reliefed Technologies AB, based in Varberg, Sweden, specializes in producing 3D printing components for various manufacturing sectors, including transportation, building materials, consumer products, and energy applications. The company has developed a globally patented 3D-production method called z.trusion®, which allows for the integration of 3D mass production into existing 2D production lines. This innovative technology significantly reduces energy consumption and costs, particularly in the new energy sector, where it can achieve up to 97% less energy usage and ten times higher production speeds. Reliefed Technologies focuses on advanced applications such as bipolar flow plates for fuel cells and electrolyzers, electrodes for lithium-ion batteries, and other energy-efficient solutions. The company is actively involved in industrialization projects with major multinational OEMs and Tier 1 suppliers, holding 44 patents across multiple countries. Through its technology, Reliefed aims to improve product performance and facilitate recycling, while also contributing to substantial savings in material and production costs.

Elicera Therapeutics is a clinical-stage immuno-oncology company based in Sweden that focuses on developing innovative cell and gene therapies to treat cancer. The company’s portfolio includes four drug candidates: two oncolytic virus therapies, ELC-100 and ELC-201, and two CAR T-cell treatments, ELC-301 and ELC-401. Additionally, Elicera has developed a universal CAR T-cell technology platform named iTANK (ELC-001), designed to enhance the efficacy of CAR T-cell therapies by enabling a multi-targeted approach against solid tumors. With its commitment to advancing immune-based cancer treatments, Elicera Therapeutics aims to improve outcomes for patients facing various forms of cancer.

Evoy is a Norwegian manufacturer of electric propulsion systems for speedboats, founded in 2018 and headquartered in Florø, Sogn og Fjordane. The company designs inboard and outboard electric motors that replace traditional diesel and gasoline engines, significantly lowering maintenance and operating costs. These electric systems operate silently, minimizing noise pollution in marine environments while providing strong performance and responsiveness. Evoy's innovative technology enables ferry and tour operators to meet sustainability goals and adhere to regulatory requirements, enhancing their operational efficiency and environmental impact.

Evoy is a Norwegian manufacturer of electric propulsion systems for speedboats, founded in 2018 and headquartered in Florø, Sogn og Fjordane. The company designs inboard and outboard electric motors that replace traditional diesel and gasoline engines, significantly lowering maintenance and operating costs. These electric systems operate silently, minimizing noise pollution in marine environments while providing strong performance and responsiveness. Evoy's innovative technology enables ferry and tour operators to meet sustainability goals and adhere to regulatory requirements, enhancing their operational efficiency and environmental impact.

Founded in 2014, Seaborg Technologies develops and operates thorium-based molten salt reactors (MSRs) for clean energy production. The company also designs software tools to assist MSR companies and aims to provide affordable, sustainable nuclear power.

Surgify is focused on the commercialization of an innovative technology designed for bone surgery, developed at Aalto University with support from the Finnish Funding Agency for Innovation. The company collaborates closely with the Neurosurgical Department of Helsinki University Central Hospital to ensure effective communication with clinicians. Surgify's technology aims to protect proximal soft structures during surgery, thereby minimizing complications such as bleeding, infections, and nerve injuries. This advancement not only enhances surgical safety but also aims to improve patient outcomes and quality of life by reducing suffering associated with these procedures.

Surgify is focused on the commercialization of an innovative technology designed for bone surgery, developed at Aalto University with support from the Finnish Funding Agency for Innovation. The company collaborates closely with the Neurosurgical Department of Helsinki University Central Hospital to ensure effective communication with clinicians. Surgify's technology aims to protect proximal soft structures during surgery, thereby minimizing complications such as bleeding, infections, and nerve injuries. This advancement not only enhances surgical safety but also aims to improve patient outcomes and quality of life by reducing suffering associated with these procedures.

TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, specializing in the development of genetically modified oncolytic viruses to enhance T-cell therapies for cancer treatment. Established in 2013, the company focuses on utilizing its patented technology to improve tumor-infiltrating lymphocyte (TIL) and chimeric antigen receptor (CAR-T) therapies, as well as checkpoint inhibiting antibody treatments. TILT Biotherapeutics is advancing products such as TILT-123, TILT-234, and TILT-321, which aim to modify the tumor microenvironment and boost immune responses against cancer. The company's innovative approach holds promise for achieving effective results in treating solid tumors, paralleling the successes seen in hematological tumors.

Founded in 2016, Carbo Culture produces biochar from waste biomass using a patented process that permanently stores carbon. Its high-quality biochar is used for soil remediation and enhancement, while also generating renewable energy and creating tangible carbon credits.

Ocean Oasis is a water technology company developing wave-powered desalination to produce fresh water from seawater and deliver it to shore with zero emissions. Its platform leverages wave energy to provide a flexible and robust solution that reduces dependence on diesel generators and electric grids, supporting decarbonization for coastal communities. The company aims to offer a cost-competitive approach to sustainable freshwater supply, combining offshore capabilities with environmentally friendly design. Founded in 2020 and based in Oslo, Norway, Ocean Oasis focuses on scalable desalination suitable for coastal infrastructure and regional water security.

Founded in 2016, Kaffe Bueno specializes in transforming coffee waste into valuable ingredients using proprietary biotechnology. The company produces coffee oils, coffee flour, and coffee beans for use in cosmetics, functional foods, and nutraceuticals, aiming to minimize harmful emissions and maximize the usability of coffee's by-products.

Comptek Solutions is a Finnish developer specializing in advanced surface engineering for compound semiconductors. Its Kontrox quantum surface engineering process creates defect-free, crystalline surfaces on III-V materials, enabling higher-quality semiconductor devices used in CMOS manufacturing, radio frequency components, optoelectronics, power electronics, and concentrated photovoltaics. Founded in 2017 and based in Turku, the company also offers passivation technologies that mitigate aggressive oxidation, reducing atomic-level defects and improving device efficiency, reliability and manufacturability. Kontrox has demonstrated substantial performance gains in devices such as microLEDs, and the company provides customized services to fit diverse substrate and fabrication flows, helping clients produce more efficient, reliable, and affordable devices across optoelectronics, RF and power electronics markets.

Founded in Sweden in 2003, Edvince is a biotechnology company dedicated to developing innovative treatments for acute stroke therapy. Its primary focus is on minimizing brain injuries and damage resulting from strokes.

Comptek Solutions is a Finnish developer specializing in advanced surface engineering for compound semiconductors. Its Kontrox quantum surface engineering process creates defect-free, crystalline surfaces on III-V materials, enabling higher-quality semiconductor devices used in CMOS manufacturing, radio frequency components, optoelectronics, power electronics, and concentrated photovoltaics. Founded in 2017 and based in Turku, the company also offers passivation technologies that mitigate aggressive oxidation, reducing atomic-level defects and improving device efficiency, reliability and manufacturability. Kontrox has demonstrated substantial performance gains in devices such as microLEDs, and the company provides customized services to fit diverse substrate and fabrication flows, helping clients produce more efficient, reliable, and affordable devices across optoelectronics, RF and power electronics markets.

Minalyze AB is a Swedish company specializing in the development of analytical instruments and software for the mining and exploration industries. Founded in 2010 and headquartered in Savedalen, Minalyze provides mobile analysis solutions that are designed to endure harsh environments. Their products enable the on-site analysis of drill samples, facilitating geological data visualization and acquisition. Minalyze offers its services at various locations worldwide, including dedicated Core Competence Centres. The company's instruments support both short-term scanning projects and long-term initiatives, providing mining and exploration companies with essential geological insights for specialized projects.

Minalyze AB is a Swedish company specializing in the development of analytical instruments and software for the mining and exploration industries. Founded in 2010 and headquartered in Savedalen, Minalyze provides mobile analysis solutions that are designed to endure harsh environments. Their products enable the on-site analysis of drill samples, facilitating geological data visualization and acquisition. Minalyze offers its services at various locations worldwide, including dedicated Core Competence Centres. The company's instruments support both short-term scanning projects and long-term initiatives, providing mining and exploration companies with essential geological insights for specialized projects.

Founded in 2019, DigiFarm is a Norwegian ag-tech company that develops deep neural network models using high-resolution satellite imagery. Its AI platform helps Norwegian farmers optimize grain production by providing crop classification models and yield data for informed decision-making.

Heart Aerospace AB, established in 2018 with headquarters in Gothenburg, Sweden, and operations in Palo Alto, California, specializes in developing electric regional airliners certified for passenger flight. The company's mission is to facilitate swift, affordable, and sustainable travel for regional journeys worldwide. Their flagship aircraft, the ES-19, is a nineteen-passenger electric airliner designed with an operating range of 400 km, aiming to reduce fuel and maintenance costs compared to traditional aircraft while emitting zero operational emissions. Heart Aerospace targets commercial operation certification for the ES-19 by 2026.

Handiscover Sweden AB is an online booking platform specializing in accommodations for individuals with physical disabilities. Founded in 2014 by Sebastien Archambeaud in response to personal experiences as a parent of a child with a muscle disease, the company is headquartered in Malmö, Sweden. Handiscover features a distinctive classification system that allows users to select accommodations based on varying levels of mobility and physical needs. This community-based platform not only enables individuals with disabilities to find suitable vacation rentals but also assists companies and municipalities in gathering and presenting essential accessibility data. By focusing on the unique requirements of its users, Handiscover aims to enhance the travel experience for people with disabilities, making it easier for them to discover and book accessible holiday accommodations.

N2 Applied is a Norwegian technology company focused on enabling farmers to produce their own sustainable fertilizer through an innovative process that utilizes slurry, air, and electricity. The company is in the pre-commercial phase and has developed a technology that allows for the local production of nitrogen-rich fertilizer from liquid organic substrates, such as livestock manure. By integrating nitrogen from the atmosphere into these substrates, N2 Applied's solution not only enhances the nitrogen content but also mitigates ammonia loss and reduces greenhouse gas emissions. The company operates its head office in Oslo/Asker and maintains a test center in Svene, with additional branches in Wageningen and York. N2 Applied's scalable process aims to eliminate the lengthy and costly supply chains associated with traditional fertilizer production, facilitating a more circular farming system. This approach not only provides farmers with cost-effective and environmentally friendly fertilizer but also contributes to on-farm reductions in methane and ammonia emissions.

Sparrow Quantum specializes in developing deterministic single-photon sources for advancing light-matter interfaces in quantum technologies. With a focus on high efficiency, purity, indistinguishability, and outcoupling, the company's technology is based on over two decades of research at the Niels Bohr Institute.

MedTrace Pharma A/S, founded in 2015 and based in Kongens Lyngby, Denmark, specializes in the development of innovative solutions for positron emission tomography (PET) imaging. The company has created an automated system, known as MT-100, which efficiently produces and injects 15O-water, a radioactive tracer essential for enhanced imaging. This system is designed to integrate seamlessly with in-house cyclotrons and PET scanners, significantly increasing the sensitivity of patient analysis while improving throughput by up to four times compared to conventional methods. Additionally, MedTrace Pharma develops the aQuant analytical platform, which aids in interpreting PET scan results, further optimizing the diagnostic process. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace is focused on advancing the capabilities of clinical imaging through automation and innovative technology.

Founded in 2016, Carbo Culture produces biochar from waste biomass using a patented process that permanently stores carbon. Its high-quality biochar is used for soil remediation and enhancement, while also generating renewable energy and creating tangible carbon credits.

Gleechi AB, established in 2014 and headquartered in Stockholm, Sweden, specializes in developing software solutions that facilitate natural interaction between humans, computers, and robots. Their core technology revolves around advanced computer vision and machine learning algorithms, enabling real-time, free, and natural hand interactions in games, virtual reality, and robotics. Gleechi's innovative software allows for the creation of realistic hand movements and interactions, making it possible for users to learn by doing in virtual environments. The company has been recognized for its achievements, including being named Super Startup of the Year by Veckans Affärer and ALMI Invest, winning the EIT Digital Idea Challenge, and being awarded Startup of the Year by STING.

NIL Technology ApS is a Danish company specializing in the optical design, prototyping, and mass production of optical components. Founded in 2006 and headquartered in Kongens Lyngby, with a branch in Gothenburg, Sweden, the company offers nanostructured masters for a variety of replication technologies, including nanoimprint and UV-replication. NIL Technology develops innovative solutions for sectors such as biotechnology, space applications, consumer product packaging, and renewable energy. Its product range encompasses diffractive optics, microlens arrays, metalenses, optical diffusers, and various optical components used in applications like augmented reality, structured light, and anti-reflection technologies. The company's expertise positions it as a key player in the optical solutions industry.

Founded in Norway in 2012, CrayoNano specializes in developing and manufacturing semiconductor components using proprietary nanomaterials technologies. The company's innovative products focus on enhancing global solutions in health, safety, water purification, consumer goods, and industrial applications.

Mode Sensors AS is a digital healthcare company based in Trondheim, Norway, specializing in hydration monitoring technology. Founded in 2016, the company has developed innovative wearable solutions, notably its flagship product, Re:Balans®, which allows for real-time, non-invasive tracking of fluid balance. This technology is designed to assist healthcare providers in assessing patients' hydration status, enabling early intervention and improved health outcomes. Mode Sensors' solutions are applicable across various sectors, including healthcare, defense, and workforce safety, and they integrate with existing remote patient monitoring systems. By focusing on user-friendly design and continuous innovation, Mode Sensors aims to optimize hydration management and enhance overall well-being and performance in diverse environments.

Mode Sensors AS is a digital healthcare company based in Trondheim, Norway, specializing in hydration monitoring technology. Founded in 2016, the company has developed innovative wearable solutions, notably its flagship product, Re:Balans®, which allows for real-time, non-invasive tracking of fluid balance. This technology is designed to assist healthcare providers in assessing patients' hydration status, enabling early intervention and improved health outcomes. Mode Sensors' solutions are applicable across various sectors, including healthcare, defense, and workforce safety, and they integrate with existing remote patient monitoring systems. By focusing on user-friendly design and continuous innovation, Mode Sensors aims to optimize hydration management and enhance overall well-being and performance in diverse environments.

Heart Aerospace AB, established in 2018 with headquarters in Gothenburg, Sweden, and operations in Palo Alto, California, specializes in developing electric regional airliners certified for passenger flight. The company's mission is to facilitate swift, affordable, and sustainable travel for regional journeys worldwide. Their flagship aircraft, the ES-19, is a nineteen-passenger electric airliner designed with an operating range of 400 km, aiming to reduce fuel and maintenance costs compared to traditional aircraft while emitting zero operational emissions. Heart Aerospace targets commercial operation certification for the ES-19 by 2026.

Founded in Norway in 2012, CrayoNano specializes in developing and manufacturing semiconductor components using proprietary nanomaterials technologies. The company's innovative products focus on enhancing global solutions in health, safety, water purification, consumer goods, and industrial applications.

Electrochaea develops and commercializes power-to-gas technology that converts renewable electricity into pipeline-grade natural gas. This enables large-scale energy storage, grid balancing, and carbon recycling.

IQM Quantum Computers, founded in 2018 and headquartered in Espoo, Finland, specializes in developing and manufacturing hardware systems for quantum computing. The company focuses on scalable hardware solutions utilizing superconducting technology to build quantum processors for universal quantum computers. By concentrating on practical applications, IQM aims to enhance quantum computing capabilities and address challenges faced by various industries and society. As a spin-out from Aalto University and the VTT Technical Research Centre of Finland, IQM has achieved significant advancements in areas such as thermal management, which are crucial for improving computational speed and information accuracy. The company's innovations position it as a leader in the global pursuit of large-scale quantum computing solutions. IQM also offers access to its hardware for research laboratories and supercomputing centers, helping businesses reduce error rates that currently limit computing performance.

Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical company based in Turku, Finland, focused on developing novel treatments for medical conditions with significant unmet needs. The company has a diverse pipeline that addresses acute trauma, cancer, and inflammatory diseases. Its lead product, Traumakine, is an investigational intravenous formulation of interferon beta-1a, currently undergoing Phase III clinical trials for treating acute respiratory distress syndrome (ARDS). Another key candidate, Clevegen, is an immunotherapy designed to prevent tumor growth and metastasis by targeting immune suppressor molecules in tumors, and is in Phase I/II development. Additionally, Faron is developing D-ARDS, a diagnostic tool aimed at assessing ARDS severity and monitoring outcomes. The company collaborates with the MediCity unit of Turku University Medical School to enhance its research and development efforts. Founded in 2003, Faron Pharmaceuticals is committed to advancing innovative solutions in healthcare.

Ilya Pharma AB, established in 2016 and headquartered in Uppsala, Sweden, specializes in developing biological drugs for treating skin and mucosal wounds. The company's innovative approach involves genetically modifying lactic acid bacteria, commonly found in yogurt, to produce substances that accelerate wound healing. Ilya Pharma focuses on both acute and chronic wounds, with a particular emphasis on addressing the unique challenges faced by diabetic patients.

Ilya Pharma AB, established in 2016 and headquartered in Uppsala, Sweden, specializes in developing biological drugs for treating skin and mucosal wounds. The company's innovative approach involves genetically modifying lactic acid bacteria, commonly found in yogurt, to produce substances that accelerate wound healing. Ilya Pharma focuses on both acute and chronic wounds, with a particular emphasis on addressing the unique challenges faced by diabetic patients.

Electrochaea develops and commercializes power-to-gas technology that converts renewable electricity into pipeline-grade natural gas. This enables large-scale energy storage, grid balancing, and carbon recycling.

Evoy is a Norwegian manufacturer of electric propulsion systems for speedboats, founded in 2018 and headquartered in Florø, Sogn og Fjordane. The company designs inboard and outboard electric motors that replace traditional diesel and gasoline engines, significantly lowering maintenance and operating costs. These electric systems operate silently, minimizing noise pollution in marine environments while providing strong performance and responsiveness. Evoy's innovative technology enables ferry and tour operators to meet sustainability goals and adhere to regulatory requirements, enhancing their operational efficiency and environmental impact.

Evoy is a Norwegian manufacturer of electric propulsion systems for speedboats, founded in 2018 and headquartered in Florø, Sogn og Fjordane. The company designs inboard and outboard electric motors that replace traditional diesel and gasoline engines, significantly lowering maintenance and operating costs. These electric systems operate silently, minimizing noise pollution in marine environments while providing strong performance and responsiveness. Evoy's innovative technology enables ferry and tour operators to meet sustainability goals and adhere to regulatory requirements, enhancing their operational efficiency and environmental impact.

Handiscover Sweden AB is an online booking platform specializing in accommodations for individuals with physical disabilities. Founded in 2014 by Sebastien Archambeaud in response to personal experiences as a parent of a child with a muscle disease, the company is headquartered in Malmö, Sweden. Handiscover features a distinctive classification system that allows users to select accommodations based on varying levels of mobility and physical needs. This community-based platform not only enables individuals with disabilities to find suitable vacation rentals but also assists companies and municipalities in gathering and presenting essential accessibility data. By focusing on the unique requirements of its users, Handiscover aims to enhance the travel experience for people with disabilities, making it easier for them to discover and book accessible holiday accommodations.

Neuro Event Labs Oy, established in 2015 and headquartered in Tampere, Finland, specializes in developing artificial intelligence-based software for epilepsy patient monitoring. Their primary product collects accurate seizure data from patients at home and in hospitals, which is then analyzed and relayed to physicians for informed treatment decisions. This solution was developed in close collaboration with leading Finnish hospitals.

IQM Quantum Computers, founded in 2018 and headquartered in Espoo, Finland, specializes in developing and manufacturing hardware systems for quantum computing. The company focuses on scalable hardware solutions utilizing superconducting technology to build quantum processors for universal quantum computers. By concentrating on practical applications, IQM aims to enhance quantum computing capabilities and address challenges faced by various industries and society. As a spin-out from Aalto University and the VTT Technical Research Centre of Finland, IQM has achieved significant advancements in areas such as thermal management, which are crucial for improving computational speed and information accuracy. The company's innovations position it as a leader in the global pursuit of large-scale quantum computing solutions. IQM also offers access to its hardware for research laboratories and supercomputing centers, helping businesses reduce error rates that currently limit computing performance.

MedTrace Pharma A/S, founded in 2015 and based in Kongens Lyngby, Denmark, specializes in the development of innovative solutions for positron emission tomography (PET) imaging. The company has created an automated system, known as MT-100, which efficiently produces and injects 15O-water, a radioactive tracer essential for enhanced imaging. This system is designed to integrate seamlessly with in-house cyclotrons and PET scanners, significantly increasing the sensitivity of patient analysis while improving throughput by up to four times compared to conventional methods. Additionally, MedTrace Pharma develops the aQuant analytical platform, which aids in interpreting PET scan results, further optimizing the diagnostic process. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace is focused on advancing the capabilities of clinical imaging through automation and innovative technology.

Neuro Event Labs Oy, established in 2015 and headquartered in Tampere, Finland, specializes in developing artificial intelligence-based software for epilepsy patient monitoring. Their primary product collects accurate seizure data from patients at home and in hospitals, which is then analyzed and relayed to physicians for informed treatment decisions. This solution was developed in close collaboration with leading Finnish hospitals.

Modvion AB is a Swedish company founded in 2015 and based in Gothenburg, specializing in the design and development of modular wind power towers constructed from renewable composite materials. The company focuses on simplifying construction logistics and improving cost efficiency in the wind energy sector through its patented modular technology. This innovative approach enables the production of wind towers exceeding 120 meters in height while significantly reducing transportation costs, installation complexity, and the reliance on traditional steel structures. By leveraging engineered wood products, Modvion aims to enhance the economic viability of wind power projects, ultimately contributing to increased electricity production and more sustainable energy solutions.

Modvion AB is a Swedish company founded in 2015 and based in Gothenburg, specializing in the design and development of modular wind power towers constructed from renewable composite materials. The company focuses on simplifying construction logistics and improving cost efficiency in the wind energy sector through its patented modular technology. This innovative approach enables the production of wind towers exceeding 120 meters in height while significantly reducing transportation costs, installation complexity, and the reliance on traditional steel structures. By leveraging engineered wood products, Modvion aims to enhance the economic viability of wind power projects, ultimately contributing to increased electricity production and more sustainable energy solutions.

Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical company based in Turku, Finland, focused on developing novel treatments for medical conditions with significant unmet needs. The company has a diverse pipeline that addresses acute trauma, cancer, and inflammatory diseases. Its lead product, Traumakine, is an investigational intravenous formulation of interferon beta-1a, currently undergoing Phase III clinical trials for treating acute respiratory distress syndrome (ARDS). Another key candidate, Clevegen, is an immunotherapy designed to prevent tumor growth and metastasis by targeting immune suppressor molecules in tumors, and is in Phase I/II development. Additionally, Faron is developing D-ARDS, a diagnostic tool aimed at assessing ARDS severity and monitoring outcomes. The company collaborates with the MediCity unit of Turku University Medical School to enhance its research and development efforts. Founded in 2003, Faron Pharmaceuticals is committed to advancing innovative solutions in healthcare.

Oivi is a Norwegian company founded in 2017 and based in Oslo, specializing in the development of an affordable AI-driven camera and platform for the identification of diabetic eye diseases. The company focuses on facilitating retinal screening in primary care settings, thereby promoting awareness and proactive management of diabetic eye health. Oivi's innovative platform employs automated image capture and diagnostic capabilities to monitor eye diseases effectively through teleconsultation. With a multifaceted team possessing extensive expertise in camera and software development, Oivi aims to empower patients to prevent permanent vision loss associated with diabetes.

Gleechi AB, established in 2014 and headquartered in Stockholm, Sweden, specializes in developing software solutions that facilitate natural interaction between humans, computers, and robots. Their core technology revolves around advanced computer vision and machine learning algorithms, enabling real-time, free, and natural hand interactions in games, virtual reality, and robotics. Gleechi's innovative software allows for the creation of realistic hand movements and interactions, making it possible for users to learn by doing in virtual environments. The company has been recognized for its achievements, including being named Super Startup of the Year by Veckans Affärer and ALMI Invest, winning the EIT Digital Idea Challenge, and being awarded Startup of the Year by STING.

Colzyx AB is a biotechnology company based in Lund, Sweden, founded in 2012, specializing in innovative wound care solutions. The company leverages groundbreaking research from the Medical Faculty at Lund University, focusing on the alpha-3 chain of human collagen VI, which has shown significant wound healing and antimicrobial properties. Colzyx develops bioactive wound dressings that harness these biological mechanisms to enhance the wound healing process while effectively combating a wide range of bacteria, including multidrug-resistant strains. Their products are designed to treat both active and chronic wounds, promoting rapid closure and reducing the risk of infections, thereby improving patient outcomes.

NIL Technology ApS is a Danish company specializing in the optical design, prototyping, and mass production of optical components. Founded in 2006 and headquartered in Kongens Lyngby, with a branch in Gothenburg, Sweden, the company offers nanostructured masters for a variety of replication technologies, including nanoimprint and UV-replication. NIL Technology develops innovative solutions for sectors such as biotechnology, space applications, consumer product packaging, and renewable energy. Its product range encompasses diffractive optics, microlens arrays, metalenses, optical diffusers, and various optical components used in applications like augmented reality, structured light, and anti-reflection technologies. The company's expertise positions it as a key player in the optical solutions industry.

NIL Technology ApS is a Danish company specializing in the optical design, prototyping, and mass production of optical components. Founded in 2006 and headquartered in Kongens Lyngby, with a branch in Gothenburg, Sweden, the company offers nanostructured masters for a variety of replication technologies, including nanoimprint and UV-replication. NIL Technology develops innovative solutions for sectors such as biotechnology, space applications, consumer product packaging, and renewable energy. Its product range encompasses diffractive optics, microlens arrays, metalenses, optical diffusers, and various optical components used in applications like augmented reality, structured light, and anti-reflection technologies. The company's expertise positions it as a key player in the optical solutions industry.

Colzyx AB is a biotechnology company based in Lund, Sweden, founded in 2012, specializing in innovative wound care solutions. The company leverages groundbreaking research from the Medical Faculty at Lund University, focusing on the alpha-3 chain of human collagen VI, which has shown significant wound healing and antimicrobial properties. Colzyx develops bioactive wound dressings that harness these biological mechanisms to enhance the wound healing process while effectively combating a wide range of bacteria, including multidrug-resistant strains. Their products are designed to treat both active and chronic wounds, promoting rapid closure and reducing the risk of infections, thereby improving patient outcomes.

Founded in 2013 as a spin-off from the University of Helsinki's Finnish Institute for Molecular Medicine, Aiforia specializes in cloud-based microscopy and pathology. Its platform combines deep learning AI and high-performance cloud computing to provide efficient, scalable solutions for image-based diagnostics across various fields.

Founded in 1995, SSH Communications Security specializes in enterprise cybersecurity solutions. It offers products like PrivX for lean access management, Universal SSH Key Manager for key management, Tectia SSH for secure file transfer, and NQX Firewall for high-security applications. The company serves over 3000 customers globally, focusing on financial institutions and other organizations needing secure data access.

Founded in 2013, RePack manufactures and sells reusable packaging bags for individuals and clothing brands worldwide. Its products include polypropylene, polyethylene, and cardboard bags that can be returned for recycling after use, with customers rewarded with vouchers for future purchases. Operating primarily online, RePack aims to reduce waste and environmental impact associated with single-use packaging.

Imaqen Ltd. is a Finnish healthcare technology company developing a new pre-screening solution for early detection of cancer. The innovation offers a non-invasive patient examination and it is suitable for use in wide range of healthcare facilities. The utilised method is protected by patents. Their team consists of experienced diagnostic imaging and clinical research professionals with solid track records in successful product development and global sales and marketing.

Valtavalo Ltd, established in 2008, specializes in the development, manufacture, and supply of energy-efficient lighting solutions in Finland and internationally. Recognized as the largest LED tube manufacturer in the Northern Countries, the company focuses on high-volume production to offer competitive pricing on advanced LED technologies, which have traditionally been perceived as costly. Valtavalo's product range includes long-lifetime LED lighting tubes equipped with replaceable light sources, allowing users to significantly lower their energy consumption, installation, and maintenance costs. Through its innovative approach, Valtavalo aims to make energy-efficient lighting accessible and affordable for a wide array of clients.

Medicortex Finland is focused on developing a non-invasive, point-of-care diagnostic test for Traumatic Brain Injury (TBI) and concussions. Traditional diagnostic methods, such as CT and MRI scans, struggle to accurately diagnose mild TBIs. To address this, Medicortex is identifying brain injury biomarkers that can be detected from urine and saliva, with plans to incorporate these biomarkers into a hand-held diagnostic kit that provides rapid and reliable results without the need for medical professionals' interpretation. The company aims to collaborate with larger diagnostic firms for manufacturing and distribution. Its target customers include hospitals, emergency rooms, paramedics, military personnel, sports teams, pharmaceutical companies, and insurance providers. Medicortex has achieved significant milestones, including reaching Phase II clinical studies for its biomarker and receiving grant funding from the US Department of Defense, the European Union, and the Finnish Government.

TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, specializing in the development of genetically modified oncolytic viruses to enhance T-cell therapies for cancer treatment. Established in 2013, the company focuses on utilizing its patented technology to improve tumor-infiltrating lymphocyte (TIL) and chimeric antigen receptor (CAR-T) therapies, as well as checkpoint inhibiting antibody treatments. TILT Biotherapeutics is advancing products such as TILT-123, TILT-234, and TILT-321, which aim to modify the tumor microenvironment and boost immune responses against cancer. The company's innovative approach holds promise for achieving effective results in treating solid tumors, paralleling the successes seen in hematological tumors.